Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Mes blogs Mes offres Mes emplois Mes cours Evènements Blogs Offres Emplois Cours Forums Film Jeux
Connexion S’enregistrer
Mode Clair
TUDRIQEV Approval for Advanced Melanoma: Regulatory Progress, Mechanism, and Clinical Outlook
Replimune has reached an important milestone in oncology with the FDA’s accelerated approval of tudriqev (vusolimogene oderparepvec-wtpg), previously identified as RP1, in combination with Bristol Myers Squibb’s OPDIVO (nivolumab). Granted on August 6, 2026, the approval applies to adults with unresectable, advanced cutaneous melanoma that has progressed after treatment with an...
0 Commentaires ·0 Parts ·207 Vue ·0 Avis
Connectez-vous pour aimer, partager et commenter!
Villagge https://villagge.com